184 results on '"Elneil S"'
Search Results
2. Prevalence of Urinary Incontinence
3. 155 POST-OPERATIVE OUTCOMES AND URODYNAMIC FINDINGS AFTER CONTINENCE MESH REMOVAL
4. Patient-tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
5. Benefits and harms of Botulinum Toxin-A in the treatment of chronic pelvic pain syndromes: Systematic review by the EAU Chronic Pelvic Pain Panel
6. The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review
7. Percutaneous tibial nerve stimulation for the treatment of the overactive bladder in patients with neurological disease: T206
8. Maintenance Percutaneous Posterior Nerve Stimulation for Refractory Lower Urinary Tract Symptoms in Patients with Multiple Sclerosis: An Open Label, Multicenter, Prospective Study
9. 3-Year Followup of a New Implantable Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome
10. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system
11. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system
12. 3-Year Followup of a New Implantable Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome
13. Obstetric fistula- a new way forward
14. Sustained and significant quality of life improvement after intra-detrusor botulinum neurotoxin type A injections for neurogenic detrusor overactivity secondary to Multiple Sclerosis: P 79
15. The experience with periodic intra-detru-sor injection of botulinum neurotoxin type-A: P27
16. Primary Evaluation of Patients Suspected of Having Interstitial Cystitis (IC)
17. The vaginal vault
18. P2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis
19. Benefits and harms of electrical neuromodulation for chronic pelvic pain: A systematic review
20. Nouveau système de neuromodulation des racines sacrées rechargeables pour le traitement de l’hyperactivité vésicale idiopathique : résultats à 12 mois d’un essai clinique, prospectif, multicentrique
21. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder
22. Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder
23. Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder
24. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder
25. Erratum to: Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance)
26. Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance)
27. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society
28. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder
29. Treatment of overactive bladder with a miniaturized rechargeable sacral neuromodulation system
30. Un système de neuromodulation sacré rechargeable pour le traitement de l’hyperactivité vésicale : résultats intermédiaires d’un essai clinique, prospectif, multicentrique
31. A0884 - Outcomes of colposuspension and paravaginal repair for the treatment of stress urinary incontinence after continence mesh removal.
32. PT335 - Benefits and harms of electrical neuromodulation for chronic pelvic pain: A systematic review
33. 949 - Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder
34. 950 - Treatment of overactive bladder with a miniaturized rechargeable sacral neuromodulation system
35. Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis
36. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis:an ESSIC proposal
37. Recommendations on the use of Botulinum toxin in the treatment of lower urinary tract (LUT) disorders and pelvic floor dysfunctions: a European consensus panel report
38. Prevalence of Urinary Incontinence
39. Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
40. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: An ESSIC proposal
41. Obstetric Fistula—A New Way Forward
42. PAW26 Are the beneficial effects of Botulinum toxin for refractory detrusor overactivity in multiple sclerosis sustained with repeat injections?
43. UP-2.44: An electronic tool to support the selection of patients with overactive bladder syndrome for sacral neuromodulation
44. 512 SACRAL NEUROMODULATION FOR NEUROGENIC LOWER URINARY TRACT DYSFUNCTION: A VALUABLE TREATMENT OPTION?
45. 67 SUSTAINED QUALITY OF LIFE IMPROVEMENT AFTER REPEAT INTRADETRUSOR INJECTIONS OF BOTULINUM NEUROTOXIN TYPE A FOR REFRACTORY IDIOPATHIC DETRUSOR OVERACTIVITY
46. SUBUROTHELIAL MUSCARINIC RECEPTORS M1, M2, M3 IN PATIENTS WITH DETRUSOR OVERACTIVITY (DO) AND THE EFFECT OF BOTULINUM TOXIN TYPE A (BONT/A)
47. 891 DETRUSOR INJECTIONS OF BOTULINUM NEUROTOXIN TYPE A (BONT/A) FOR THE TREATMENT OF BLADDER SYMPTOMS OF MULTIPLE SCLEROSIS (MS)
48. 478 10-YEAR EXPERIENCE OF SACRAL NEUROMODULATION IN URINARY RETENTION - RESULTS FROM UK TERTIARY REFERRAL CENTRE
49. 892 THE IMMEDIATE EFFECT INTRADETRUSOR INJECTIONS OF BOTULINUM NEUROTOXIN A (BONT/A) ON THE SYMPTOMS OF THE OVERACTIVE BLADDER SYNDROME
50. 589 FEMALE VOIDING DYSFUNCTION -THE UK EXPERIENCE (2001-2006)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.